Thomas Fremming Dejgaard (Thomas F Dejgaard)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Diabetes, obesity & metabolism

Diabetologia

The Journal of clinical endocrinology and metabolism

Journal of the Endocrine Society

Steno Diabetes Center Copenhagen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Steno Diabetes Center Copenhagen

Denmark

Medical Doctor

Nordsjællands Hospital Mar 01 2017

Denmark

Medical Doctor :: Cardiology, Nephrology and Endocrinology

Hvidovre Hospital - Feb 28 2017

Denmark

Medical Doctor :: Department of Endocrinology

Publications

Thomas Fremming Dejgaard, Christian S Frandsen, Urd Kielgast, Joachim Størling, Anne J Overgaard, Maria S Svane, Markus Harboe Olsen, Birger Thorsteinsson, Henrik U Andersen, Thure Krarup, Jens Juul Holst, Sten Madsbad
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism (2024)
Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris Neumann Nielsen, Natasha Chidekel Bergmann, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens Juul Holst, Flemming Dela, Julie Overgaard, Joachim Størling, Tina Vilsbøll, Thomas Fremming Dejgaard, Jesper Foged Havelund, Vladimir A Gorshkov, Frank Kjeldsen, Nils Joakim Færgeman, Martin Rønn Madsen, Mikkel Bring Christensen, Filip K Krag Knop
GIP Affects Hepatic Fat and Brown Adipose Tissue Thermogenesis but Not White Adipose Tissue Transcriptome in Type 1 Diabetes. The Journal of clinical endocrinology and metabolism 107 (12) (2022)
Thorbjörn Åkerström, Malene Norup Stolpe, Renate Widmer, Thomas Fremming Dejgaard, Jens M Højberg, Kirsten Møller, Jakob S Hansen, Beckey Trinh, Jens Juul Holst, Carsten Thomsen, Bente Klarlund Pedersen, Helga Ellingsgaard
Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women. Journal of the Endocrine Society 6 (9) (2022)
Signe Schmidt, Christian S Frandsen, Thomas Fremming Dejgaard, Dorte Vistisen, Thórhallur Halldórsson, Sjudur F Olsen, Jens-Erik B Jensen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes, obesity & metabolism (2021)
Nicklas Järvelä Johansen, Thomas Fremming Dejgaard, Asger Lund, Camilla Schlüntz, Bolette Hartmann, Jens J Holst, Tina Vilsbøll, Henrik U Andersen, Filip K Krag Knop
Effects of short-acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes. Diabetes, obesity & metabolism (2021)
Sebastian Møller Nguyen Heimbürger, Bjørn Hoe, Chris N Nielsen, Natasha Chidekel Bergmann, Bolette Hartmann, Jens Juul Holst, Tina Vilsbøll, Thomas Fremming Dejgaard, Mikkel Bring Christensen, Filip K Krag Knop
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial. Diabetologia 64 (11) (2021)
Thomas Fremming Dejgaard, Bernt J von Scholten, Erik Christiansen, Frederik F Kreiner, Lars Bardtrum, Matthias von Herrath, Chantal Mathieu, Sten Madsbad, null null
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials. Diabetes, obesity & metabolism 23 (12) (2021)
Nicklas Järvelä Johansen, Thomas Fremming Dejgaard, Asger Lund, Camilla Schlüntz, Emil List Larsen, Henrik E Poulsen, Jens P Goetze, Holger J Møller, Tina Vilsbøll, Henrik U Andersen, Filip K Krag Knop
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trial. Diabetes, obesity & metabolism 22 (9) (2020)
Marit Eika Jørgensen, Martin Bæk Blond, Lea Bruhn, Hanan Amadid, Dorte Vistisen, Kim Katrine Bjerring Clemmensen, Camilla T R Vainø, Camilla Pedersen, Maria Overvad, Thomas Fremming Dejgaard, Kristian Karstoft, Mathias Ried-Larsen, Stephen C Bain, Marit Eika Jorgensen
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial. Diabetologia 64 (1) (2020)
Thomas Fremming Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial. Diabetes, obesity & metabolism 22 (4) (2019)

Thomas Fremming Dejgaard.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas F Dejgaard)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Fremming Dejgaard (Thomas F Dejgaard)